FindMyKOL
Clinical trialNCT06965504Not, yet, recruitingInterventional

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

SponsorAbiomed Inc.Enrollment250Cardiogenic ShockHeart FailureReduced Ejection Fraction Heart Failure
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in patients with decompensated heart failure and cardiogenic shock.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Tampa General Hospital

    Tampa, Florida, United States

    Debbie Rinde-Hoffman, MD, FACC, FACP, FHFSA
  • Abbott Northwestern

    Minneapolis, Minnesota, United States

    Kasia Hryniewicz, MD
  • Rutgers-Robert Wood Johnson Medical School

    New Brunswick, New Jersey, United States

    Maya Guglin, MD, PhD
  • Atrium Health

    Charlotte, North Carolina, United States

    Priyesh Patel, M.D.
  • Duke University

    Durham, North Carolina, United States

    Adam DeVore, MD, MHS, FHFSA, FAHA, FACC
  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, United States

    Joyce Wald, DO, FACC
  • Centennial Medical Center

    Nashville, Tennessee, United States

    Thomas McRae, MD, FACCZachary J II'Giovine, MD, FACC

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2026
Primary completion
1 Dec 2028
Completion
1 Jun 2029
Last update posted
23 Apr 2026
Registered enrollment
250
Registry id
NCT06965504
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.